Actinogen Medical (FRA:3AC) Days Inventory: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Actinogen Medical Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Actinogen Medical's Average Total Inventories for the six months ended in Jun. 2026 was €0.00 Mil. Actinogen Medical's Cost of Goods Sold for the six months ended in Jun. 2026 was €0.13 Mil. Hence, Actinogen Medical's Days Inventory for the six months ended in Jun. 2026 was 0.00.

The historical rank and industry rank for Actinogen Medical's Days Inventory or its related term are showing as below:

FRA:3AC's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 184.66
* Ranked among companies with meaningful Days Inventory only.

Actinogen Medical's Days Inventory stayed the same from Jun. 2025 () to Jun. 2026 ().

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Actinogen Medical  (FRA:3AC) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Actinogen Medical's Inventory Turnover for the six months ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.12562764611499 / 0
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Actinogen Medical's Inventory to Revenue for the six months ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Actinogen Medical Days Inventory Related Terms

Actinogen Medical Days Inventory Historical Data

* Premium members only.

The historical data trend for Actinogen Medical's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actinogen Medical Days Inventory Chart

Actinogen Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Actinogen Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FRA:3AC vs VRTX, REGN, MRNA: Days Inventory Comparison

For the Biotechnology subindustry, Actinogen Medical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actinogen Medical Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Days Inventory distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Days Inventory falls into.


Actinogen Medical Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Actinogen Medical's Days Inventory for the fiscal year that ended in Jun. 2026 is calculated as

Days Inventory (A: Jun. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Jun. 2025 ) + Total Inventories (A: Jun. 2026 )) / count ) / Cost of Goods Sold (A: Jun. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0.24357714074381*365
=0 / 0.24357714074381*365
=0.00

Actinogen Medical's Days Inventory for the quarter that ended in Jun. 2026 is calculated as:

Days Inventory (Q: Jun. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Jun. 2026 )) / count ) / Cost of Goods Sold (Q: Jun. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0.12562764611499*365 / 2
=0 / 0.12562764611499*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actinogen Medical Business Description

Other Exchanges ATGGF:USAACW:Australia
Address 109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated cortisol in the brain. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.